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3-[2-(2,4,6-Trimethylphenyl)thioethyl]-4-methylsydnone was shown to be a potent porphyrinogenic agent 
in chick embryo liver cells. The accumulation of protoporphyrin IX was consistent with the finding that 
ferrochelatase activity was inhibited. 3-Benzyl-4-phenylsydnone did not inhibit ferrochelatase activity and 
protopo~hyrin IX was found to constitute only a minor fraction of the porphyrins. These results support 
the idea that the po~hy~nogenicity of 3-[2-(2,4,6-trimethylphenyl)thioethyl]~methylsydnone is due to its 
catalytic activation by cytochrome P-450 leading to heme alkyiation and formation of N-vinyiprotopor- 
phyrin IX which inhibits ferrochelatase. 
Porphyria Ferrochelatase N-Alkylprotophyrin Sydnone Cytochrome P-&O (Chick embryo liver) 
1. INTRODUCTION 
The dihydropyridine, 35diethoxycarbonyl-1,4- 
dihydro-2,4,6_trimethylpyridine, when adminis- 
tered to rodents, causes the accumulation in the 
liver of N-methylprotoporphyrin IX, a potent in- 
hibitor of ferrochelatase (EC 4.99.1.1) activity 
[l-3]. The source of the N-methyl substituent of 
~-methylprotoporphyrin is the cl-methyl group of 
the dihydropyridine 14-61. The dihydropyridine 
and several 4-alkyl analogues serve as suicide 
substrates of cytochrome P-450 [3,5]. Although 
there are a large number of chemicals which ex- 
hibit porphyrinogenicity, dihydropyridines which 
cause inhibition of ferrochelatase activity appeared 
to have a unique mechanism of action, particularly 
in chick embryo liver [7]. A report by Stejskal et al. 
[S] using 3-[2-(2,4,6-trimethylphenyl)thioethyl]- 
4-methylsydnone (fig. la) suggested that the mech- 
anism of action of dihydropyridines as porphy- 
rinogenic agents might not be unique. Thus, the 
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sydnone (fig.la), which was developed as a poten- 
tial anti-arthritic agent, was reported to produce 
hepatic porphyria in dogs, rats and mice. The fact 
that the hepatic pigment was interpreted to be pro- 
toporphyrin IX suggested that the sydnone might 
be a suicide substrate for cytochrome P-450 and 
give rise to an N-alkylprotoporphyrin IX which in- 
hibited ferrochelatase 191. In the studies of Stejskal 
et al. [8], the hepatic pigment was only tentatively 
identified as protoporphyrin IX by its red autoflu- 
N-O 
Ph 
Fig. 1. (a) 3-[2-(2,4,6-Tr~methylpheny~)thi~thyf]-4-meth- 
ylsydnone, (b) 3-benzyl-4-phenylsydnone. 
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orescence in ultraviolet light and by its birefrin- 
gence. The objectives of this study were to confirm 
the structure of the pigment by biochemical 
methods and to determine whether the sydnone 
had ferrochelatase-inhibitory activity. Because of 
its sensitivity to porphyrinogenic agents [lo], the 
chick embryo liver cell culture was selected for the 
study. 
2. EXPERIMENTAL 
2.1. Determination of ferrochelatase activity 
Details of the cell culture technique have been 
described [11,12]. After an initial incubation 
period of 24 h, the medium was discarded and 
replaced with fresh medium. After a further 24 h 
incubation period, a sydnone, dissolved in 95% 
ethanol, was added to the dishes (maximal total 
volume added 20 ~1). Ferrochelatase activity was 
assayed 6 h after addition of a sydnone as in 
[7,11,13] by a modification of the pyridine 
hemochromogen method [14] using mesopor- 
phyrin and ferrous iron as substrates. 
2.2. Determination of total porphyrins and 
porphyrin precursors 
For determination of total porphyrins and por- 
phyrin patterns, chick embryo liver cells were 
maintained in 6-cm diameter dishes containing 5 
ml medium. Drugs were dissolved in 95% ethanol 
to the dishes (maximal total volume 15 ~1). Total 
porphyrins were measured 24 h after addition of 
the drugs [15]. Porphyrin patterns were deter- 
mined as described [7,1 l] by the high-performance 
liquid chromatographic method of Zelt et al. [16]. 
Results were calculated as pmol porphyrin per mg 
protein. 
3. RESULTS AND DISCUSSION 
Doses of 0.01, 0.1, 1.0 and 10.0 fig/ml of 
3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethyl- 
pyridine and the sydnone (fig.la) were compared 
for porphyrinogenic activity in chick embryo liver 
cells (fig.2); the results show that the sydnone 
(fig.la) is considerably more potent than the 
dihydropyridine as a porphyrinogenic agent. Doses 
of 0.1 and 1 /cg/ml of the dihydropyridine and syd- 
none (fig. la) were compared for ferrochelatase- 
inhibitory activity in chick embryo liver cells 
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Fig.2. Porphyrin accumulation 24 h after the addition 
of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethyl- 
pyridine (DDC), 3-benzyl-4-phenylsydnone (BPS), 
and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsyd- 
none(TTMS) to chick embryo liver cell culture. Each bar 
represents the mean of 4 determinations f SD in one ex- 
periment and the results were confirmed in 2 additional 
experiments. * Significantly different from control by 
Newman-Keuls test (psO.05). 
Fig.3). The sydnone (fig.la) at 0.1 and 1.0 pg/ml 
was shown to have ferrochelatase-inhibitory activi- 
ty (fig.3). According to current ideas, the dihydro- 
pyridine owes its porphyrinogenic action to (i) fer- 
rochelatase inhibition via N-alkylprotoporphyrin 
IX formation, and (ii) a second mechanism where- 
by an elevation of &aminolevulinic acid synthetase 
(EC 2.3.1.37) is induced independent of inhibition 
of heme biosynthesis or of stimulation of heme 
degradation [17]. It has been pointed out that all 
drugs that induce b-aminolevulinic acid synthetase 
by this second mechanism have the property of 
lipid solubility [17]. It is likely that the sydnone 
similarly owes its porphyrinogenic action to the ac- 
Volume 197, number 1,2 
CONTROL BPS 
“; 6.0 
._ 
E 1 
- 
DDC 
* 
II- 
1 
- 
I 
FEBS LETTERS March 1986 
TTMS 
* 
0.1 0.11.0 0.1 1.0 
DRUG CONCENTRATION (liglml) 
Fig.3. Ferrochelatase activity in chick embryo liver cell 
cultures cell cultures 6 h after addition of 3,5diethoxy- 
carbonyl-1,4-dihydro-2,4,6-trimethylp~idine (DDC), 
3-benzyl-4-phenylsydnone (BPS), 3-[2-(2,4,6trimethyl- 
phenyl)thioethyl]-4-methylsydnone (TTMS). Each bar 
represents the mean of 4 determinations f SD in one ex- 
periment and the results were confirmed in 2 additional 
experiments. * Significantly different from control by 
Newman-Keuls tests 0, $ 0.05). 
tion described above. The higher porphyrinogeni- 
city observed with sydnone (fig.la) than with the 
dihydropyridine (fig.2) despite its lower 
ferrochelatase-inhibitory potency (fig.3) might 
therefore be attributable to higher lipophilicity. 
The pattern of porphyrin accumulation induced by 
the sydnone (fig.la) in chick embryo liver cells was 
examined by high-performance liquid chromatog- 
raphy (fig.4); protoporphyrin IX was the major 
porphyrin to accumulate (approximately 85%). 
This pattern of porphyrin accumulation is similar 
to that observed with the dihydropyridine (fig.4) 
and is consistent with the observation that the syd- 
none (fig.la) inhibits ferrochelatase. It was con- 
cIuded that (i) Stejskal et al. [8] were correct in 
their identification of the hepatic pigment as pro- 
toporphyrin IX, and (ii) that protoporphyrin IX 
accumulated due to the ferrochelatase-inhibitory 
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Fig.4. Porphyrin patterns obtained 24 h after the addi- 
tion of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-tri- 
methylpyridine (DDC), 3-benzyl-4-phenylsydnone 
(BPS), 3-[2-(2,4,~trimethylphenyl)thioethyl]-4-methyl- 
sydnone (TTMS) (3 &g/ml medium) to chick embryo 
liver cell cultures. Numbers under the bars indicate the 
number of carboxyl groups (8, uropo~hyrin; 7, hep- 
tacarboxylic porphyrin; 6, hexacarboxylic porphyrin; 5, 
pentacarboxylic porphyrin; 4, coproporphyrin; 2,proto- 
porphyrin). Each bar represents he mean f SD of 4 
determinations in one experiment and the results were 
confirmed in 2 additional experiments. 
activity of the sydnone (fig.la). 
The sydnone (fig.la) has been shown to cause 
suicidal inactivation of cytochrome P-450 when in- 
cubated with liver microsomes from phenobar- 
bital-pretreated rats [9,18]. Following administra- 
tion of the sydnone (fig.la) to phenobarbital- 
pretreated rats, an ~-alkylporph~in was isolated 
from the liver and shown to be a mixture of the 
regio isomers of N-vinylprotoporphyrin IX. The 
lowering of ferrochelatase activity (fig.3) caused 
by the sydnone (fig.la) is therefore presumably 
due to ferrochelatase inhibition exerted by the 
regioisomers of N-vinylprotoporphyrin IX. The 
formation of N-vinylprotoporphyrin has been sug- 
gested to occur as follows : the sydnone (fig. la) is 
catalytically activated by cytochrome P-450 fol- 
lowed by heme alkylation of cytochrome P-450 by 
a fragment of the sydnone (fig.la), viz. a vinyl 
group [18]. According to this scheme 1181 the vinyl 
group is derived from the two carbon atoms in the 
thioethyl fragment of the 3-substituent of the syd- 
19 
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none (fig.la). To test this scheme, 3-benzyl-4- 
phenylsydnone (fig. lb), which lacked a thioethyl 
fragment in the 3-position, and therefore could not 
be activated to form N-vinylprotoporphyrin IX 
was investigated. 3-Benzyl-4-phenylsydnone did 
not inhibit ferrochelatase (fig.3) and protopor- 
phyrin IX was found to constitute only a minor 
fraction (16%) of the porphyrins which ac- 
cumulated (fig.4). These results support the 
scheme, suggested for formation of N-vinylproto- 
porphyrin IX from the sydnone (fig.la). Since 
3-benzyl-4- phenylsydnone does not lower ferro- 
chelatase activity (fig.3) its porphyrinogenicity 
(figs 2 and 4) presumably resides in its property of 
lipophilicity. 
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